Automated Biobanking - The Next Big Leap for Biorepositories
 

Automated Biobanking - The Next Big Leap for Biorepositories

on

  • 2,365 views

An analyst briefing about automated biobanking and what is next for biorepositories.

An analyst briefing about automated biobanking and what is next for biorepositories.

Statistics

Views

Total Views
2,365
Views on SlideShare
2,345
Embed Views
20

Actions

Likes
1
Downloads
47
Comments
0

2 Embeds 20

http://www.linkedin.com 14
http://www.gilcommunity.com 6

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Automated Biobanking - The Next Big Leap for Biorepositories Automated Biobanking - The Next Big Leap for Biorepositories Presentation Transcript

    • Automated Biobanking-The Next Big Leap for Biobanking- Biorepositories Divyaa Ravishankar, Senior Research Analyst Healthcare 24 April 2012© 2012 Frost & Sullivan. All rights reserved. This document contains highly confidential information and is the sole property ofFrost & Sullivan. No part of it may be circulated, quoted, copied or otherwise reproduced without the written approval of Frost & Sullivan.
    • Today’s Presenter Functional Expertise 7 years of life sciences expertise which mainly constitutes lab research and market research.Place photo here Working with new technologies incorporated in lab research.Shadow Background Identifying emerging technologies and tracking technological and market developmentsfor effect across the life sciences domain. Competitive Intelligence, Qualitative Research (Primary and Secondary Research),Competitive Analysis, Company Best Practices Analysis, Spreadsheet Market Sizing and Forecasting Models, Research Design, Client Relationship Management. Industry ExpertiseDivyaa Ravishankar Lab research experience in the areas such as:Senior Research - Diagnostic Testing by Immuno-Chromatographic Techniques.Analyst, - Genetic Testing & HLA typing. Experience base covering broad range of sectors, leveraging long-standing workingHealthcare - Europe relationships with leading industry participants globally in areas like: Frost & Sullivan - Drug Discovery - Clinical Diagnostics - Pharmaceuticals and Biotechnology - Donor Registries Education • Master of Science (Hons.) in Biological Sciences from Birla Institute of Technology and Science, Pilani, India. 2
    • Focus Points Automated Biobanking – The Next Big Leap for Biorepositories Automated Biobanking Global Overview – Key Segments of 1. Growth 2. Industry Drivers & Challenges 3. Biobanking Needs – Demand AnalysisFocus Points 4. Segment wise – Key Market Participants 5. Regional Focus and Key projects 6. Key Strategies and Conclusions 3
    • Market Overview • Analyze the dynamics and trends of automation into the biobanking sector and project the future outlook forGoal the various segments globally for the base year 2011 and the forecast period 2012-2018. Market Definition . • Biobanks range from informal storage of hundreds of specimen in an individual freezer to large scale formal repositories that manage millions of specimens. Market Segments . • Liquid handling and robotics, Automated compound storage and other sample management systems, LIMS and Consumables Market Summary • The global automation market for biobanking application in 2011 accounted for $818.0 Million growing at a CAGR of 8.2 percent. • Each year around 100 million samples are being added to the biobanks worldwide. 4
    • Segment Overview Revenue by Segment Source: Frost & Sullivan analysis. Automated Automated Laboratory Compound Liquid Handling Information Storage & Sample Consumables Systems & Management Management Robotics Systems (LIMS) systems• Robotic arms and automated sample • Solutions that help in: processors • Automated Sample retrieval , Vials,Seals• Nucleic acid preparation storage and management. Barcode labels, systems • Automated management of Data management of biosample Tips,• Fractionation systems sample libraries storage- aided by various Deep well Microplate• Low volume and high • Large and small-scale storage sample management softwares Microfuge volume sample dispensing of compounds held in varying Tubes/Storage Tubes workstations plate and tube formats• Bench top pipetting • Ambient to -80 degree cold platforms stores• Multiprobe dispensing heads 5
    • Workflow and Equipment PortfolioBiobanking Workflow Equipment Portfolio Sample Collection Transportation Sample Processing and Liquid Handling Sample LIMS Processing Automated Cold Storage LIMS Sample Storage Consumables Analysis, Reporting and Billing Analytical Tools Source: Frost & Sullivan analysis. 6
    • Challenges and Drivers Challenges Technological challenges arising due to comparison of research results obtained by using specimens from two different biobanks as no two biobanks operate in a similar way. Funding and financial maintenance of public biobanks infrastructure becoming tougher in the long run. Automation in the area of sample storage and retrieval systems still immature for ultra low temperatures and longer durations.Opportunities Increased growth perceived in Europe and Asia owing to upcomingpopulation and disease based biobank projects. Automation increases the efficiency of a biobank. Increased LIMS capabilities enhance the prospects and degree ofautomation within the biobank community. Source: Frost & Sullivan. 7
    • Demand Analysis Key Findings of Frost & Sullivan End User Survey Dash Board Organizational Challenges Biobank Access Score Free & 5 Completely Restricted Free 50.0%Obtaining Funding for Systems 25.0% 0 10 Low High 5 Support from Upper Management 0 10 Low High Both Free & Only Paid Paid Source: Frost & Sullivan analysis. 5.0% 5 Services 20.0% Qualified Staff to Operate 0 10 Interest in Automation Low High 5Time and Resource for Training on System 0 10 Low High Justify ROI/ System 5 Accountability 0 10 Low High 10 being high level challenge;5 being medium level challenge Source: Frost & Sullivan analysis. 0 being low level challenge 8
    • Key Market Participants Key Segment Participants Tecan Beckman Coulter Eppendorf Hamilton Perkin Elmer Thermo Fisher Scientific Automated LiquidHandling & robotics Autogen Agilent TAP Biosystems Brooks Life Science Hudson Robotics Cybio Technologies Brooks Life Science TTP Labtech TAP BiosystemsAutomated Compound Storage & SampleManagement systems Matrical Biosciences Liconic Instruments Thermo Fisher Scientific Ocimum Thermo Fisher Scientific Starlims Corp Biosolutions LIMS Labvantage Labware Perkin Elmer Autoscribe Corning Life Micronic Wheaton Eppendorf TAP Biosystems Tecan Science Consumables Thermo Fisher Matrical Greiner Bio - One Hamilton Bioscience Brooks Life Science Scientific Source: Frost & Sullivan analysis. 9
    • Regional AnalysisRegional Revenue Contribution Growth Rate Trends Source: Frost & Sullivan analysis. Source: Frost & Sullivan analysis. NORTH AMERICA EUROPE ASIA Rest of World The United States Western Europe India Africa Canada Eastern Europe East Asia (China. Korea, Taiwan) South America Oceania (Australia and South East Asia ( Malaysia, Singapore, Indonesia ) New Zealand) Middle East Asia 10
    • Strategic Conclusions & Recommendations So What? The falling cost of genomic technologies is Strategic alliances and partnerships with expanding the scale and technology leaders, academic biobanks and scope of biobanking small regional participants will enhance market research. penetration. Understanding the needs of the biobank and Pharma companies are addressing the infrastructure limitations is the moving towards key to the success of automation systems.outsourcing to third party biobanks. Adapting open standards in development alleviates compatibility issues Vertical integration is one of the ongoing methods to tide over the different technologies existent for laboratory automation in a cost- effective manner Source: Frost & Sullivan analysis. 11
    • Legal DisclaimerFrost & Sullivan takes no responsibility for the incorrect information supplied to us bymanufacturers or users. Quantitative market information is based primarily on interviewsand therefore is subject to fluctuation. Frost & Sullivan research services are limitedpublications containing valuable market information provided to a select group ofcustomers. Our customers acknowledge, when ordering or downloading, that Frost &Sullivan Research Services are for customers’ internal use and not for general publicationor disclosure to third parties. No part of this Research Service may be given, lent, resold ordisclosed to noncustomers without written permission. Furthermore, no part may bereproduced, stored in a retrieval system, or transmitted in any form or by any means,electronic, mechanical, photocopying, recording or otherwise, without the permission of thepublisher.• For information regarding permission, write to: Frost & Sullivan 331 E. Evelyn Ave. Suite 100 Mountain View, CA 94041 12
    • Next StepsDevelop Your Visionary and Innovative Skills Growth Partnership Service Share your growth thought leadership and ideas or join our GIL Global Community Join our GIL Community Newsletter Keep abreast of innovative growth opportunities 13
    • Your Feedback is Important to Us What would you like to see from Frost & Sullivan?Growth Forecasts?Competitive Structure?Emerging Trends?Strategic Recommendations?Other? Please inform us by “Rating” this presentation. 14
    • Follow Frost & Sullivan onFacebook, LinkedIn, SlideShare, and Twitter http://www.facebook.com/FrostandSullivan http://www.linkedin.com/companies/4506 http://www.slideshare.net/FrostandSullivan http://twitter.com/frost_sullivan 15
    • For Additional InformationJanique Morvan Noel AndersonCorporate Communications European Vice PresidentHealthcare New Business Development+ 33 (0) 679 22 4142 +44 (0) 207 343 8389janique.morvan@frost.com noel.anderson@frost.comRanjith Gopinathan Siddharth SahaProgram Manager Director of ResearchHealthcare Healthcare0091 (0) 44 66814242 0044 (0) 207 343 8374ranjith.gopinathan@frost.com siddharth.saha@frost.com